Cytokine Release Syndrome More than Two Years after Pembrolizumab Introduction.

MLA

Kazuhisa Nakashima, et al. “Cytokine Release Syndrome More than Two Years after Pembrolizumab Introduction.” Internal Medicine, vol. 63, no. 15, Aug. 2024, pp. 2163–66. EBSCOhost, https://doi.org/10.2169/internalmedicine.2347-23.

APA

Kazuhisa Nakashima, Kashu Kitani, Kento Kono, Ken Yoshihara, Keita Kawakado, Misato Kobayashi, Takae Okuno, Yoshihiro Amano, Yukari Tsubata, & Takeshi Isobe. (2024). Cytokine Release Syndrome More than Two Years after Pembrolizumab Introduction. Internal Medicine, 63(15), 2163–2166. https://doi.org/10.2169/internalmedicine.2347-23

Chicago

Kazuhisa Nakashima, Kashu Kitani, Kento Kono, Ken Yoshihara, Keita Kawakado, Misato Kobayashi, Takae Okuno, Yoshihiro Amano, Yukari Tsubata, and Takeshi Isobe. 2024. “Cytokine Release Syndrome More than Two Years after Pembrolizumab Introduction.” Internal Medicine 63 (15): 2163–66. doi:10.2169/internalmedicine.2347-23.